Vallis, K., Reilley, R., Scollard, D., Petronis, J., Caldwell, C., Hendler, A., . . . Oza, A. (2005). A phase I clinical trial to evaluate the pharmacokinetics, toxicity and dosimetry of 111-indium-labeled human epidermal growth factor in patients with metastatic breast cancer.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিVallis, K., R. Reilley, D. Scollard, J. Petronis, C. Caldwell, A. Hendler, G. Lockwood, এবং A. Oza. A Phase I Clinical Trial to Evaluate the Pharmacokinetics, Toxicity and Dosimetry of 111-indium-labeled Human Epidermal Growth Factor in Patients with Metastatic Breast Cancer. 2005.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিVallis, K., et al. A Phase I Clinical Trial to Evaluate the Pharmacokinetics, Toxicity and Dosimetry of 111-indium-labeled Human Epidermal Growth Factor in Patients with Metastatic Breast Cancer. 2005.